List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
○List of trading stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1885> Toaken 1019 995 <1941> Chudenko 3280 3130 <1944> Kinden 3264 3162 <2121> MIXI 3040 2955 <2157> Koshidaka HD 886 806 <2207> Meito
List of Cloud Breakout Stocks [Ichimoku Balance Table, List of Cloud Breakout Stocks]
* Cloud breakthrough stock list Market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Prime <2201> Morinaga Kajuu 2566 2509.75 2559.5 <2501> Sapporo HD 6242 5411.25 5719.5 <2767> Tsuburaya Pro HD 1717 1581.25 1710 <2815> Ariake
JCR Pharmaceuticals Engages Community With Plant Tour
JCR Pharmaceuticals Revamps Executive Structure
JCR Pharmaceuticals: Interim report
JCR Pharmaceuticals Partially Corrects Consolidated Results for Fiscal Year 2024
JCR Pharmaceuticals (TYO:4552) has made corrections to the consolidated results for the fiscal year ended March 31, (Japanese standard), according to its filing on Thursday. The group said the correct
JCR Pharmaceuticals: (Correction- Numerical Data Correction) Partial correction of the Financial results briefing[Japan Standard] (Consolidated) for the fiscal year ending March 2024.
JCR Pharmaceuticals FY Net Y5.51B Vs Net Y3.77B
JCR Pharmaceuticals Co. Ltd. (4552.TO) Japan Year Ended March 31 GROUP 2024 2023 Revenue Y42.87 bln Y34.34 bln Operating Profit Y7.53 bln
JCR Pharmaceuticals: Confirmation letter
JCR Pharmaceuticals: Securities report - 49th period (April 1, 2023 - March 31, 2024)
Hitachi, Shizuoka FG, etc. (additional) Rating
Upgrade - Bullish Code | Stock Name | Securities Company | Conventional | After Modification | ----- | ------------ - | ---------- | ------------ | --------- | <3923> | Lax | Nomura | "Neutral" | "Buy" | <5947> | Rinnai | SMBC Nikko | "3" | "2" | <9142> | JR Kyushu | SMBC Nikko | "3"
Stocks that moved the day before part 1: sea, Kanamoto, Migarohd, etc.
Stock Name <Code> 10 Day Closing Price ⇒ Day-Over-Day Showcase <3909> 305 +12 Cybozu has released a beta version of an AI assistant to support business on kintone. LandNet <2991> 1196 +55 Operating profit for the third quarter increased 37.4% from the previous quarter's 6.7% increase, expanding profit growth rate. NuLabo <5033> 940 +32 Decided to hold events for 'Backlog' nationwide. Cladas <5884> 310.
Migaro HD, Shiono Yakuyaku, Ain HD, etc.
<4552> JCR Pharma fell significantly by 11 points. Morgan Stanley MUFG Securities downgraded its investment rating from 'overweight' to 'equal weight' and lowered its target stock price from 1700 yen to 590 yen. As the expectation for major new drug Catalyst from 2026 to 2027 becomes more difficult, and the possibility of changes in the partnership with Takeda related to Izcargo increases, it is a matter of concern. Profits from new drugs can be felt in the fiscal year ending March 2030.
JCR Pharma - downgraded by US securities as timing for revenue growth is delayed
JCR Pharma <4552> falls. Morgan Stanley MUFG Securities downgrades investment rating from "overweight" to "equal weight" and lowers target stock price from 1700 yen to 590 yen. Concerns include the difficulty of expecting a major new drug catalyst from 2026 to 2027, as well as the possibility of changes in the partnership with Takeda regarding Izcargo. Profit growth from new drugs can only be realized in 2030.
Sekisui House, Maruichi Kan, etc. (added) Rating.
Upgrade to a bullish rating code | Stock name | Securities firm | Conventional | After change | ------ | ------------- | ---------- | -------------- | -------------- | <1801> | Taisei Construction | SMBC Nikko | "2" | "1" | <3002> | Gunze | Daiwa | "3" | "2"
Rating [security companies rating]
Upgrade - bullish code | Stock Name | Brokerage | Former | After change | ------ | ------------ | ---------- | ------------- | ----------------- | <6367> | Daikin | Mito | "B" | "B+" | <3765> | Gan Ltd | Ichiyoshi | "B" | "A" |
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
List of buy conversion stocks Market Code Name Close SAR Tokyo Prime <3788> GMO-GS 2940 2751 <3861> Oji HD 634 614 <3939> Kanamic N 512 472 <4021> Nissan Chemical 4620 4289 <4028> Ishihara Sangyo
JCR Pharmaceuticals' Full-Year Profit Up 46%
JCR Pharmaceuticals (TYO:4552) recorded a 46% rise in attributable profit for the year ended March 31 to 5.51 billion yen from 3.77 billion yen during the year-ago period, a delayed filing posted on t
Jefferies Adjusts JCR Pharmaceuticals' Price Target to 560 Yen From 1,200 Yen, Keeps at Hold
05:19 AM EDT, 05/27/2024 (MT Newswires) -- Jefferies Adjusts JCR Pharmaceuticals' Price Target to 560 Yen From 1,200 Yen, Keeps at Hold
Sumiseki HD, Teijin, Okamura Foods, etc.
<6125> Okamoto Koki 5150 +305 continues to increase drastically. A capital and business alliance with Mitsui & Co., Ltd. has been announced. A third-party allotment of shares was implemented for Mitsui & Co., and Mitsui & Co., Ltd. became the largest shareholder holding 29.71%. In addition to semiconductor-related equipment and machine tool businesses, partnerships in human resource strategies and corporate functions will also be carried out. It is at a high level with a dilution rate of 42.09% due to capital increases, but beyond that, effects such as strengthening sales power associated with partnership effects are expected. <8771>
No Data